156774-71-9

Basic information

• Product Name: 2-phenyl-cyclopent-1-enecarboxylic acid
• Synonyms: 2-phenyl-cyclopent-1-enecarboxylic acid
• CAS NO: 156774-71-9
• Molecular Weight: 188.226
• Mol File: 156774-71-9.mol

Chemical Properties

• CAS DataBase Reference: 2-phenyl-cyclopent-1-enecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-phenyl-cyclopent-1-enecarboxylic acid(156774-71-9)
• EPA Substance Registry System: 2-phenyl-cyclopent-1-enecarboxylic acid(156774-71-9)

Safety Data

• Hazardous Substances Data: 156774-71-9(Hazardous Substances Data)

Upstream product

• 741689-33-8 2-phenyl-cyclopent-1-enecarboxylic acid amide 
• 611-10-9 2-ethoxycarbonyl-1-cyclopentanone 
• 122539-74-6 2-trifluoromethanesulfonyloxy-cyclopent-1-enecarboxylic acid ethyl ester 
• 27326-83-6 ethyl 2-phenyl-1-cyclopentene-1-carboxylate 
• 156774-70-8 2-phenylcyclopent-1-enecarboxylic acid methyl ester 

Downstream Products

• 741689-33-8 2-phenyl-cyclopent-1-enecarboxylic acid amide 
• 1501-05-9 5-oxo-5-phenylvaleric acid 
• 156774-62-8 (3S-trans)-N-(6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-2-phenyl-1-cyclopentenamide 
• 951742-84-0 (-)-2-phenyl-cyclopentanecarboxylic acid 
• 7015-25-0 (+/-)-cis-2-phenyl-cyclopentane-carboxylic acid-⁽¹⁾ 

Relevant articles and documents

Rhodium-catalyzed and zinc(II)-triflate-promoted asymmetric hydrogenation of tetrasubstituted α,β-unsaturated ketones

The asymmetric hydrogenation of tetrasubstituted α,β-unsaturated ketones has been accomplished using an in situ formed rhodium-Josiphos catalyst. The reaction is enhanced by addition of catalytic zinc(II) triflate, which significantly improves turnover fr

Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids

The present invention relates to a process for the preparation of cis substituted cyclic β-aryl or heteroaryl carboxylic acid derivatives in high diastereo- and enantioselectivity by enantioselective hydrogenation in accordance with the following scheme w

3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES

This invention relates to tricyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction, the compounds having general structure (I).